Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Penicillin Challenge in Patients with History of Non-Life Threatening Allergy
NCT00363688Phase 4Terminated
- Sponsor
- Meir Medical Center
- Start
- Jan 1998
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of phenoxymethylpenicillin and amoxicillin in bacterial infection, sponsored by Meir Medical Center. Primary endpoint: Results of an oral challenge with penicillin (penicillin V) and amoxicillin. Started Jan 1998; status: terminated.
02
Drugs
phenoxymethylpenicillinamoxicillin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT00363688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00363688.